Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Vaccine ; 38(7): 1723-1729, 2020 02 11.
Article in English | MEDLINE | ID: mdl-31892447

ABSTRACT

To control foot-and-mouth disease (FMD) outbreaks that originated in Jincheon County in South Korea between 2014 and 2015, several commercial vaccines were studied for their efficacy and serological performance in the field. In this study, the efficacy of the O SKR 7/10 vaccine was evaluated by challenge with the FMD virus (FMDV) O/Jincheon/SKR/2014 (O Jincheon), which has the same O/SEA/Mya-98 lineage as the O/SKR/7/10 strain that was isolated in 2010 in South Korea, in FMD-seronegative pigs. Full protection against the O Jincheon virus was demonstrated as early as 14 days postvaccination, which was explained by the strong serological relationship (r1 value: ≥ 0.92) between the O Jincheon and O SKR 2010 viruses. However, in the field trial, no satisfactory serological elevations against FMDV were observed, even in the double-vaccinated groups. Therefore, it can be concluded that the O SKR 7/10 vaccine may need to be improved to overcome the interference effects from the high levels of maternally-derived antibodies generated due to the mandatory nationwide vaccination of sows in South Korea.


Subject(s)
Antibodies, Viral/blood , Foot-and-Mouth Disease , Immunity, Maternally-Acquired , Viral Vaccines/immunology , Animals , Emulsions , Female , Foot-and-Mouth Disease/prevention & control , Foot-and-Mouth Disease Virus/immunology , Republic of Korea , Swine/immunology
2.
Vaccine ; 37(12): 1702-1709, 2019 03 14.
Article in English | MEDLINE | ID: mdl-30712811

ABSTRACT

After massive foot-and-mouth disease (FMD) outbreaks originated from Jincheon County from Dec. 2014 to Apr. 2015, the effectiveness of the previous FMD vaccine containing only the O1 Manisa as the O antigen, O1 Manisa + A Malaysia 97 + Asia 1 Sharmir trivalent vaccine, was questioned in South Korea, and a change in the O antigen in FMD vaccines was demanded to control the FMD caused by FMDV O/Jincheon/SKR/2014, the O Jincheon strain. Therefore, the efficacies of O1 Manisa + O 3039 bivalent vaccine and O 3039 monovalent vaccine were studied for cross-protection against heterologous challenge with the O Jincheon strain. In this study, the efficacy of the O1 Manisa + O 3039 bivalent vaccine was better than that of the O 3039 monovalent vaccine, even though the serological relationship (r1 value) between O Jincheon and O 3039 was matched according to the OIE Terrestrial Manual. According to serological test results from vaccinated specific pathogen free pigs, virus neutralization test titers against Jincheon were good estimates for predicting protection against challenge. A field trial of the O1 Manisa + O 3039 bivalent vaccine was performed to estimate the possibility of field application in conventional pig farms, especially due to concerns about the effect of maternally derived antibodies (MDA) in field application of the FMD vaccine. According to the result of the field trial, the O1 Manisa + O 3039 bivalent vaccine was considered to overcome MDA. The results of the efficacy and field trials indicated that the O1 Manisa + O3039 vaccine could be suitable to replace previous FMD vaccines to control the FMD field situation caused by O Jincheon FMDV.


Subject(s)
Antigens, Viral/immunology , Cross Protection/immunology , Foot-and-Mouth Disease Virus/immunology , Foot-and-Mouth Disease/prevention & control , Swine Diseases/prevention & control , Viral Vaccines/immunology , Animals , Antibodies, Viral/immunology , Clinical Trials as Topic , Foot-and-Mouth Disease Virus/genetics , Swine , Vaccination
3.
Appl Environ Microbiol ; 81(21): 7610-4, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26319879

ABSTRACT

Three out of five outbreaks of foot-and-mouth disease (FMD) since 2010 in the Republic of Korea have occurred in the winter. At the freezing temperatures, it was impossible to spray disinfectant on the surfaces of vehicles, roads, and farm premises because the disinfectant would be frozen shortly after discharge and the surfaces of the roads or machines would become slippery in cold weather. In this study, we added chemical deicers (ethylene glycol, propylene glycol, sodium chloride, calcium chloride, ethyl alcohol, and commercial windshield washer fluid) to keep disinfectants (0.2% citric acid and 4% sodium carbonate) from freezing, and we tested their virucidal efficacies under simulated cold temperatures in a tube. The 0.2% citric acid could reduce the virus titer 4 logs at -20°C with all the deicers. On the other hand, 4% sodium carbonate showed little virucidal activity at -20°C within 30 min, although it resisted being frozen with the function of the deicers. In conclusion, for the winter season, we may recommend the use of citric acid (>0.2%) diluted in 30% ethyl alcohol or 25% sodium chloride solvent, depending on its purpose.


Subject(s)
Carbonates/metabolism , Citric Acid/metabolism , Disinfectants/metabolism , Foot-and-Mouth Disease Virus/drug effects , Virus Inactivation , Cold Temperature , Ethanol/metabolism , Republic of Korea , Sodium Chloride/metabolism , Time Factors , Viral Load
4.
Hybridoma (Larchmt) ; 31(5): 358-63, 2012 Oct.
Article in English | MEDLINE | ID: mdl-23098303

ABSTRACT

The foot and mouth disease virus (FMDV) is an RNA virus composed of single stranded positive sense RNA. FMDV has been known to infect cloven-hoofed animals, including pigs, cattle, and sheep. FMDV is rapidly spreading outward to neighboring regions, often leading to a high mortality rate. Thus, early diagnosis of FMDV is critical to suppress propagation of FMDV and minimize economic losses. In this study, we report the generation and characterization of polyclonal and six monoclonal antibodies against VP1 through immunoblotting and immunofluorescence microscopy analyses. These VP1 antibodies will be useful as tools to detect serotypes A and O of FMDVs for diagnostic usage.


Subject(s)
Antibodies, Monoclonal/immunology , Antibodies, Viral/immunology , Antibody Specificity , Antigens, Viral/immunology , Capsid Proteins/immunology , Foot-and-Mouth Disease Virus/immunology , Animals , Antibodies, Monoclonal/biosynthesis , Antibodies, Viral/biosynthesis , Antigens, Viral/administration & dosage , Antigens, Viral/genetics , Binding Sites, Antibody , Blotting, Western , Capsid Proteins/administration & dosage , Capsid Proteins/genetics , Escherichia coli/genetics , Female , Foot-and-Mouth Disease Virus/chemistry , Gene Expression , Hybridomas/immunology , Immunization , Mice , Mice, Inbred BALB C , Microscopy, Fluorescence , Rabbits , Recombinant Proteins/administration & dosage , Recombinant Proteins/genetics , Recombinant Proteins/immunology , Serotyping
SELECTION OF CITATIONS
SEARCH DETAIL
...